GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biomerica Inc (NAS:BMRA) » Definitions » Cyclically Adjusted PB Ratio

Biomerica (Biomerica) Cyclically Adjusted PB Ratio : 0.82 (As of May. 26, 2024)


View and export this data going back to 1978. Start your Free Trial

What is Biomerica Cyclically Adjusted PB Ratio?

As of today (2024-05-26), Biomerica's current share price is $0.626. Biomerica's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 was $0.76. Biomerica's Cyclically Adjusted PB Ratio for today is 0.82.

The historical rank and industry rank for Biomerica's Cyclically Adjusted PB Ratio or its related term are showing as below:

BMRA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.74   Med: 3.68   Max: 15.88
Current: 0.82

During the past years, Biomerica's highest Cyclically Adjusted PB Ratio was 15.88. The lowest was 0.74. And the median was 3.68.

BMRA's Cyclically Adjusted PB Ratio is ranked better than
78.34% of 471 companies
in the Medical Devices & Instruments industry
Industry Median: 2.13 vs BMRA: 0.82

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Biomerica's adjusted book value per share data for the three months ended in Feb. 2024 was $0.464. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.76 for the trailing ten years ended in Feb. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biomerica Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Biomerica's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomerica Cyclically Adjusted PB Ratio Chart

Biomerica Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.20 9.39 4.92 4.43 1.76

Biomerica Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.47 1.76 1.65 1.22 1.61

Competitive Comparison of Biomerica's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Biomerica's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomerica's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biomerica's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biomerica's Cyclically Adjusted PB Ratio falls into.



Biomerica Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biomerica's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.626/0.76
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomerica's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 is calculated as:

For example, Biomerica's adjusted Book Value per Share data for the three months ended in Feb. 2024 was:

Adj_Book=Book Value per Share/CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=0.464/130.9299*130.9299
=0.464

Current CPI (Feb. 2024) = 130.9299.

Biomerica Quarterly Data

Book Value per Share CPI Adj_Book
201405 0.784 100.373 1.023
201408 0.755 100.352 0.985
201411 0.723 99.635 0.950
201502 0.708 99.032 0.936
201505 0.740 100.333 0.966
201508 0.730 100.548 0.951
201511 0.721 100.135 0.943
201602 0.704 100.040 0.921
201605 0.639 101.355 0.825
201608 0.632 101.617 0.814
201611 0.605 101.829 0.778
201702 0.567 102.779 0.722
201705 0.527 103.256 0.668
201708 0.504 103.587 0.637
201711 0.472 104.072 0.594
201802 0.464 105.052 0.578
201805 0.487 106.148 0.601
201808 0.455 106.383 0.560
201811 0.475 106.338 0.585
201902 0.424 106.649 0.521
201905 0.411 108.048 0.498
201908 0.371 108.245 0.449
201911 0.343 108.519 0.414
202002 0.450 109.139 0.540
202005 1.208 108.175 1.462
202008 1.068 109.662 1.275
202011 0.945 109.793 1.127
202102 0.862 110.968 1.017
202105 0.750 113.576 0.865
202108 0.704 115.421 0.799
202111 0.701 117.269 0.783
202202 0.759 119.703 0.830
202205 0.647 123.323 0.687
202208 0.621 124.958 0.651
202211 0.537 125.607 0.560
202302 0.444 126.928 0.458
202305 0.697 128.314 0.711
202308 0.640 129.538 0.647
202311 0.558 129.548 0.564
202402 0.464 130.930 0.464

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biomerica  (NAS:BMRA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biomerica Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Biomerica's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomerica (Biomerica) Business Description

Traded in Other Exchanges
N/A
Address
17571 Von Karman Avenue, Irvine, CA, USA, 92614
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
Executives
John P. Kenny director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Zacharys Irani director, officer: Cheif Executive Officer 17571 VON KARMAN AVE., IRVINE CA 92614
Gary Lu officer: Chief Financial Officer 12136 AHERN CT, TUSTIN CA 92782
Allen Barbieri director
Catherine Coste director 966 OCHO RIOS DR, DANVILLE CA 94526
David Moatazedi director C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Steven Sloan officer: Chief Financial Officer 114 TERRAPIN, IRVINE CA 92618
Mark A Sirgo director C/O BIODELIVERY SCIENCES INTERNATIONAL, 801 CORPORATE CENTER DRIVE -SUITE 210, RALEIGH NC 27607
Francis Cano director 11 ACORN LANE, LOS ALTOS CA 94022
Francis E Capitanio officer: President-diagnostics 1533 MONROVIA AVENUE, NEWPORT BEACH CA 92663
Janet Moore director, 10 percent owner, officer: Secretary 1533 MUNROVIA AVE, NEWPORT BEACH CA 92663
Jane Emerson director 1533 MONROVIA AVE, NEWPORT BEACH CA 92663
William Snider other: Greater than 5% holder 4800 MONTGOMERY LANE, SUITE 230, BETHESDA MD 20814
Broadoak Fund The other: Greater than 5% holder 7201 WISCONSIN AVE. #630, BETHESDA MD 20814
John Roehm director 1533 MONROVIA AVE., NEWPORT BEACH CA 92663